Jump ahead to 2015, CVS Health acquired Target's pharmacy and retail clinic businesses.
CVS Health beat Wall Street's second-quarter earnings for 2019 and revenue expectations and raised its full-year forecast.
Here are some of the highlights from its latest earnings report:
- Adjusted earnings for the three months ending in June 2019 came in at $1.89 per share, up 11.8% from the same period last year
- Group revenues rose 35.2% from 2018 to $63.4 billion
- Looking into 2019, CVS narrowed and raised its full-year earnings forecast to a range of $6.89 to $7.00 per share, up from a prior estimate of $6.75 to $6.90
- Pharmacy Services revenues rose 4.2% to $34.8 billion
- Retail sales rose 3.7% to $21.447 billion, even as same-store sale growth slowed to 3.8%
- The group's healthcare benefits division saw sales surge from 764 million to $17.4 billion as it added Aetna's operations to its legacy business
Ready to Retire: The Biggest Threat to Your Retirement? Check Your Basement
TheStreet Feature:What Are Tariffs and Why Do They Move the Market?
Dog Days of Summer: How Consumers Will be Impacted by the September Tariffs
Catch Up: Today's Top News Videos Below